MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/mds.26085

Медицинская библиотека · Movement disorders : official journal of the Movement Disorder Society · 2014

Dysport and Botox at a ratio of 2.5:1 units in cervical dystonia: a double-blind, randomized study.

Yun Ji Young, Kim Jae Woo, Kim Hee-Tae, Chung Sun Ju, Kim Jong-Min, Cho Jin Whan, Lee Jee-Young, Lee Ha Neul, You Sooyeoun, Oh Eungseok, Jeong Heejeong, Kim Young Eun, Kim Han-Joon, Lee Won Yong, Jeon Beom S

СтатьяМногоцентровое исследованиеРандомизированное исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

We aimed to compare Dysport (abobotulinumtoxinA, Ipsen Biopharm, Slough, UK) and Botox (onabotulinumtoxinA, Allergan, Irvine, CA, USA) at a 2.5:1 ratio in the treatment of cervical dystonia (CD). A Dysport/Botox ratio of lower than 3:1 was suggested as a more appropriate conversion ratio, considering its higher efficacy and more frequent incidence of adverse effects not only in the treatment of CD but also in other focal movement disorders. A randomized, double-blind, multicenter, non-inferiority, two-period crossover study was done in CD, with a duration of at least 18 months. Patients were randomly assigned to treatment for the first period with Dysport or Botox, and they were followed up for 16 weeks after the injection. After a 4-week washout period, they were switched to the other formulation and then followed up for 16 weeks. The primary outcome was the changes in the Tsui scale between the baseline value and that at 1 month after each injection. A total of 103 patients were enrolled, and 94 completed the study. Mean changes in the Tsui scale between baseline and 4 weeks after each injection tended to favor Botox; however, this was not statistically significant (4.0 ± 3.9 points for the Dysport treatment vs. 4.8 ± 4.1 points for Botox; 95% confidence interval, -0.1-1.7; P = 0.091). The mean change of the Toronto western spasmodic torticollis rating scale score, the proportion of improvement in clinical global impression and patient global impression, and the incidences of adverse events were not significantly different between the two treatments. With regard to safety and efficacy, Dysport was not inferior to Botox in patients with CD at a conversion factor of 2.5:1. [clinicaltrial.gov: NCT00950664]

Для цитирования: Yun Ji Young, Kim Jae Woo, Kim Hee-Tae, Chung Sun Ju, Kim Jong-Min, Cho Jin Whan, Lee Jee-Young, Lee Ha Neul, You Sooyeoun, Oh Eungseok, Jeong Heejeong, Kim Young Eun, Kim Han-Joon, Lee Won Yong, Jeon Beom S. Dysport and Botox at a ratio of 2.5:1 units in cervical dystonia: a double-blind, randomized study.. Movement disorders : official journal of the Movement Disorder Society. 2014. DOI: 10.1002/mds.26085.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.